269 related articles for article (PubMed ID: 23724141)
21. Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38.
Bhonde MR; Hanski ML; Stehr J; Jebautzke B; Peiró-Jordán R; Fechner H; Yokoyama KK; Lin WC; Zeitz M; Hanski C
Int J Cancer; 2010 Jun; 126(12):2813-25. PubMed ID: 19739070
[TBL] [Abstract][Full Text] [Related]
22. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
23. Mispair-specific recruitment of the Mlh1-Pms1 complex identifies repair substrates of the Saccharomyces cerevisiae Msh2-Msh3 complex.
Srivatsan A; Bowen N; Kolodner RD
J Biol Chem; 2014 Mar; 289(13):9352-64. PubMed ID: 24550389
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.
Ladd B; Ackroyd JJ; Hicks JK; Canman CE; Flanagan SA; Shewach DS
DNA Repair (Amst); 2013 Dec; 12(12):1114-21. PubMed ID: 24231389
[TBL] [Abstract][Full Text] [Related]
25. Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells.
Fedier A; Fowst C; Tursi J; Geroni C; Haller U; Marchini S; Fink D
Br J Cancer; 2003 Oct; 89(8):1559-65. PubMed ID: 14562032
[TBL] [Abstract][Full Text] [Related]
26. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer.
Edwards RA; Witherspoon M; Wang K; Afrasiabi K; Pham T; Birnbaumer L; Lipkin SM
Cancer Res; 2009 Aug; 69(16):6423-9. PubMed ID: 19638594
[TBL] [Abstract][Full Text] [Related]
28. Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth.
Somuncu B; Ekmekcioglu A; Antmen FM; Ertuzun T; Deniz E; Keskin N; Park J; Yazici IE; Simsek B; Erman B; Yin W; Erman B; Muftuoglu M
PLoS One; 2022; 17(6):e0268391. PubMed ID: 35657956
[TBL] [Abstract][Full Text] [Related]
29. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
[TBL] [Abstract][Full Text] [Related]
30.
Villahermosa D; Christensen O; Knapp K; Fleck O
G3 (Bethesda); 2017 May; 7(5):1463-1473. PubMed ID: 28341698
[TBL] [Abstract][Full Text] [Related]
31. Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
Zeghari-Squalli N; Raymond E; Cvitkovic E; Goldwasser F
Clin Cancer Res; 1999 May; 5(5):1189-96. PubMed ID: 10353756
[TBL] [Abstract][Full Text] [Related]
32. Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1.
Hinrichsen I; Ernst BP; Nuber F; Passmann S; Schäfer D; Steinke V; Friedrichs N; Plotz G; Zeuzem S; Brieger A
Mol Cancer; 2014 Jan; 13():11. PubMed ID: 24456667
[TBL] [Abstract][Full Text] [Related]
33. Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.
Sawant A; Kothandapani A; Zhitkovich A; Sobol RW; Patrick SM
DNA Repair (Amst); 2015 Nov; 35():126-36. PubMed ID: 26519826
[TBL] [Abstract][Full Text] [Related]
34. MLH1 mediates cytoprotective nucleophagy to resist 5-Fluorouracil-induced cell death in colorectal carcinoma.
Manzoor S; Saber-Ayad M; Maghazachi AA; Hamid Q; Muhammad JS
Neoplasia; 2022 Feb; 24(2):76-85. PubMed ID: 34952246
[TBL] [Abstract][Full Text] [Related]
35. Human MLH1 protein participates in genomic damage checkpoint signaling in response to DNA interstrand crosslinks, while MSH2 functions in DNA repair.
Wu Q; Vasquez KM
PLoS Genet; 2008 Sep; 4(9):e1000189. PubMed ID: 18787700
[TBL] [Abstract][Full Text] [Related]
36. Potential of the Akt inhibitor LY294005 to antagonize the efficacy of Cisplatin against HCT116 tumor cells in a DNA mismatch repair-dependent manner.
Fedier A; Erdmann R; Boulikas T; Fink D
Int J Oncol; 2006 Nov; 29(5):1303-10. PubMed ID: 17016665
[TBL] [Abstract][Full Text] [Related]
37. RAD51D protects against MLH1-dependent cytotoxic responses to O(6)-methylguanine.
Rajesh P; Rajesh C; Wyatt MD; Pittman DL
DNA Repair (Amst); 2010 Apr; 9(4):458-67. PubMed ID: 20133210
[TBL] [Abstract][Full Text] [Related]
38. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.
Davis TW; Wilson-Van Patten C; Meyers M; Kunugi KA; Cuthill S; Reznikoff C; Garces C; Boland CR; Kinsella TJ; Fishel R; Boothman DA
Cancer Res; 1998 Feb; 58(4):767-78. PubMed ID: 9485033
[TBL] [Abstract][Full Text] [Related]
39. MSH3 protein expression and nodal status in MLH1-deficient colorectal cancers.
Laghi L; Bianchi P; Delconte G; Celesti G; Di Caro G; Pedroni M; Chiaravalli AM; Jung B; Capella C; de Leon MP; Malesci A
Clin Cancer Res; 2012 Jun; 18(11):3142-53. PubMed ID: 22496206
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of hMLH1 correlates with reduced 5-fluorouracil-mediated apoptosis in colon cancer cells.
Fujita H; Kato J; Horii J; Harada K; Hiraoka S; Shiraha H; Sakaguchi K; Shiratori Y
Oncol Rep; 2007 Nov; 18(5):1129-37. PubMed ID: 17914563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
